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INTRODUCTION 
Temporary Anchorage Devices (TADs) is a therapeutic 
alternative to traditional methods of anchorage in ortho-
dontic treatment. The intraoperative pain control by 
means of local anaesthesia is an intrinsic part of the 
procedure of TAD placement. Infiltration or topical 
local anaesthetics can be used in TAD placement [1].  
Local anaesthetics abolish sensation (and, in higher con-
centrations, motor activity) in a limited area of the body 
by reversibly blocking impulse conduction along nerve 
axons and other excitable membranes that use sodium 
channels as the primary means of action potential gener-
ation without producing unconsciousness [2,3]. 
Systemic absorption of injected local anaesthetic from 
the site of administration is determined by several fac-
tors, including dosage, site of injection, drug-tissue 
binding, local tissue blood flow, use of vasoconstrictors 
(e.g. adrenaline/epinephrine), and the physicochemical 
properties of the drug itself [2].  
In clinical practice, a vasoconstrictor, usually adrenaline 
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is often added to local anaesthetics [4].  
Adverse reactions of Lignocaine are directly proportion-
al to its concentration achieved in the circulation. The 
systemic manifestations of the combination involve the 
Central nervous system [3], Cardiovascular system [4], 
Psychogenic Reactions, allergic reactions [5] and local 
tissue damage [6]. 
In view of the use of the above-mentioned modalities 
with advantages and disadvantages of each of them, it 
was thought prudent to evaluate safety in terms of Mod-
ified Treatment Tolerability Evaluation Score (MTTES) 
of use Lignocaine with or without adrenaline (1:80000). 
MATERIAL AND METHODOLOGY    
Study design: The study was a longitudinal study 
Ethical approval: The study was commenced after 
obtaining the institutional ethical committee clearance 
and obtaining written informed consent from the patient. 
Study location & period: Carried out in Department of 
Orthodontics & Dentofacial Orthopaedics, Rural Dental 
College, Loni, from 2017 to 2019.  
Inclusion criteria: The study population included all 
patients of both gender and aged above 12 years, who 
were scheduled for placement of Temporary Anchorage 
Devices (TAD) and received topical Lignocaine aerosol 
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15%, or Injection Lignocaine 2% with or without adren-
aline in orthodontic treatment, willing to participate in 
the study were included in the study. The number of 
sites and details of TAD placement in terms of side and 
quadrant was recorded. 
Grouping: Depending on the local anaesthetic used the 
patients were divided into Group 1 (Topical Lignocaine 
Aerosol 15% USP + Lignocaine 2% with Adrenaline), 
Group 2 (Lignocaine 2%) and Group 3 (Lignocaine 2% 
with Adrenaline). 
Methodology: All the groups were assessed for imme-
diate adverse drug reactions.  The severity of adverse 
effects was graded by using Modified Treatment Tolera-
bility Evaluation Score (MTTES) for the signs and 
symptoms listed below [7]:  
Score 0: Symptom is not present (Absent) 
Score 1: Symptom is present but is not annoying or 
troublesome (Mild) 
Score 2: Symptom is frequently troublesome but would 
not interfere with normal daily activity or sleep 
(Moderate) 
Score 3: Symptom is sufficiently troublesome to inter-
fere with normal daily activity or sleep (Severe) 
RESULTS  
In the present study, 60 patients were recruited, of 
which 22 were males and 38 were females.  
Table 1: Comparison of Mean Age in three treat-
ment groups 
 
There was no statistically significant difference between 
mean ages of patients in the three groups (P= 0.49, 
ANOVA). Thus the groups are comparable age wise. 
When the distribution of patients in the groups with 
respect to gender was considered, as shown in Table no. 
Group Age (Mean ±SD) Anova 
1 21.15±6.23 0.49 
2 19.11±4.02 
3 20±5.2 
Total 20.12±5.24   
2, there is no statistically significant difference between 
the treatment groups (P= 0.653, Chi-square)  
Table 2: Gender wise distribution of three treatment 
groups 
 
Table no. 3 shows comparison of Local reactions after 
administration of anesthetic preparations. Applying Krus-
kal Waillis Test there was a statistically significant differ-
ence (P=0.004) in the number of swelling reported be-
tween three groups. There was no significant difference in 
reporting of other local reactions between the three 
groups. 
Post hoc analysis by Dunn’s test shows that Group 1 pa-
tients reported significantly higher MTTES scores as 
compared to group 2 & 3. 
Table no. 4 shows a Comparison of CNS symptoms after 
administration of anesthetic preparations. On applying 
Kruskal Wallis Test, there was statistically significant 
difference between Headache (p=0.002), Blurring Vision 
(p=0.02), numbness of tongue (p=0.006), metallic taste 
(p<0.001) Dysarthria (p=0.01) & Sedation (p=0.009). 
There was no significant difference in reporting of other 
CNS symptoms between the three groups. 
Post hoc analysis (Dunn’s test) shows that Group 1 pa-
tients reported significantly higher MTTES scores for 
Headache, Dizziness, numbness of tongue, metallic taste, 
dysarthria, & Sedation as compared to group 2 followed 
by group 3. 
Table no. 5 displays a comparison of CVS symptoms af-
ter administration of anesthetic preparations. On Applying 
Kruskal Waillis Test, there was statistically significant 
difference (p<0.001) in the number of patients reporting 
Hypertension between three groups. There was no signifi-
cant difference in reporting of other CVS symptoms be-
tween the three groups. 
 
Group (N) Male (%) Female (%) Chi square 
1 (20) 6 (30) 14 (70) 0.653 
2 (10) 9 (44.4) 10 (55.6) 
3 (22) 8 (36.4) 14 (63.6) 
Total (60) 22(36.7) 38 (63.3)   
Int. j. clin. biomed. res. 2019;5(4):21-24 
Nikita et al.   MTTS score in patients undergoing TAD under topical Lignocaine aerosol with Lignocaine with or without Adrenaline infiltration  
Local Reactions 
No. of cases 
Group 1 
  MTTES scores 
Group 2 
 MTTES scores 
Group 3 
MTTES scores 
0 1 2 3 0 1 2 3 0 1 2 3 
Pain 14 6 0 0 13 5 0 0 14 8 0 0 
Swelling 9 9 2 0 16 2 0 0 20 1 1 0 
Necrosis 20 0 0 0 18 0 0 0 21 1 0 0 
Delayed wound healing 20 0 0 0 18 0 0 0 22 0 0 0 
Table 3: Comparison of Local reactions after administration of anesthetic preparations 
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Post hoc analysis (Dunn’s test) shows that Group 1 pa-
tients reported significantly higher MTTES scores for 
hypertension as compared to group 3 followed by group 
2. (table 5) 
Table no. 6 shows a Comparison of mean Total MTTES 
Score between three anesthetic preparations. There was 
statistically significant difference between the mean 
MTTES score among the groups (p<0.001, ANOVA). It 
was lowest in Group 2 (2.06, 1.55) followed by Group 3 
(2.45, 2.19). It was significantly higher in Group 1 
(6.75, 1.94) 
Table 6: Comparison of mean Total MTTES Score 
between three anesthetic preparations 
 
Group Mean ANOVA 
1 6.75±1.94   
p<0.001 
2 2.06±1.55 
3 2.45±2.19 
Total 3.77±2.86 
DISCUSSION 
Dental practitioners use local anesthetic injections with 
various concentrations of adrenaline. In this study, the 
use of local anesthetic alone or along with adrenaline 
was found for the TAD placement. 
In Patients of Group 1 (n=20), Topical Lignocaine Aer-
osol 15% USP was followed by infiltration of   Ligno-
caine 2% with Adrenaline (1:80000). The use of topical 
anesthetic is very common before infiltrative anesthesia 
to decrease the discomfort in the application of the latter 
[8]. 
Regarding the infiltrative anesthetic, used in patients of 
Group 3 (n=22), lidocaine hydrochloride + adrenaline
(epinephrine) 1:80,000 in Group 3 was used because it 
is mostly employed in Dentistry with low toxicity rates 
and enough anesthetic effect. Additionally, this combi-
nation is injected in the area of the mucosa where the 
mini implant would be placed by infiltration in such a 
way that satisfactory anesthesia is achieved without 
making the surrounding structures from being anesthe-
tized, as suggested by the literature [9]. 
Int. j. clin. biomed. res. 2019;5(4):21-24 
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CNS 
No. of cases 
Group 1 
  MTTES scores 
Group 2 
 MTTES scores 
Group 3 
MTTES scores 
0 1 2 3 0 1 2 3 0 1 2 3 
Light-headedness 16 4 0 0 14 3 1 0 21 1 0 0 
Headache 5 11 4 0 12 6 0 0 18 2 2 0 
Dizziness 9 11 0 0 14 4 0 0 21 1 0 0 
Blurring of vision 15 4 1 0 18 0 0 0 22 0 0 0 
Tinnitus 20 0 0 0 18 0 0 0 22 0 0 0 
Perioral tingling 20 0 0 0 18 0 0 0 22 0 0 0 
Numbness of tongue 13 7 0 0 18 0 0 0 22 0 0 0 
Metallic taste 3 13 4 0 15 3 0 0 14 8 0 0 
Dysarthria 14 6 0 0 18 0 0 0 22 0 0 0 
Sedation 12 8 0 0 14 4 0 0 22 0 0 0 
Muscular twitching/tremors 20 0 0 0 18 0 0 0 22 0 0 0 
Seizures 20 0 0 0 18 0 0 0 22 0 0 0 
Coma 20 0 0 0 18 0 0 0 22 0 0 0 
Respiratory Arrest 20 0 0 0 18 0 0 0 22 0 0 0 
Table 4: Comparison of CNS symptoms after administration of anesthetic preparations 
Table 5: Comparison of CVS symptoms after administration of anesthetic preparations 
CVS No. of cases 
Group 1 
  MTTES scores 
Group 2 
 MTTES scores 
Group 3 
MTTES scores 
0 1 2 3 0 1 2 3 0 1 2 3 
Bradycardia 20 0 0 0 18 0 0 0 22 0 0 0 
Hypotension 20 0 0 0 16 2 0 0 22 0 0 0 
Hypertension 9 6 5 0 18 0 0 0 16 6 0 0 
Cyanosis 20 0 0 0 18 0 0 0 22 0 0 0 
Chest pain 20 0 0 0 18 0 0 0 22 0 0 0 
Cardiac arrhythmia 20 0 0 0 18 0 0 0 22 0 0 0 
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As seen from Table no.1 and 2, there was not-
statistically significant difference between the age and 
gender of the three groups, indicating that the groups 
were comparable with respect to age and gender.  
Post hoc analysis shows that Group 1 patients reported 
significantly higher MTTES scores as compared to 
group 2 & 3 for the symptom of pain. Pain at the site of 
implant and swelling were as the most common local 
symptoms (Table 3). 
Topical anesthetics used in Group 1 is indicated to mini-
mize the sensation of needle insertion or for very brief 
relief from painful mucosal lesions. Their effectiveness 
in preventing pain due to injection is equivocal, but they 
may be of value for many patients [3]. 
Localized toxicity occurs following the injection of lo-
cal anaesthetic directly into a structure or when a struc-
ture is exposed to a high concentration for a prolonged 
period. Direct injection into a muscle provokes an in-
tense inflammatory reaction resulting in areas of muscle 
necrosis, which is worsened by added vasoconstrictors 
[10]. 
There was statistically significant difference between 
Headache (p=0.002), Blurring Vision (p=0.02), numb-
ness of tongue (p=0.006), metallic taste (p<0.001) Dys-
arthria (p=0.01) & Sedation (p=0.009). There was no 
significant difference in the reporting of other CNS 
symptoms between the three groups. Post hoc analysis 
shows that Group 1 patients reported significantly high-
er MTTES scores for Headache, Dizziness, numbness of 
tongue, metallic taste, dysarthria, & Sedation as com-
pared to group 2 followed by group 3. (Table 4). 
In our study there was statistically significant difference 
(p<0.001) in the number of patients reporting Hyperten-
sion between three groups. There was no significant 
difference in reporting of other CVS symptoms between 
the three groups. Post hoc analysis shows that Group 1 
patients reported significantly higher MTTES scores for 
hypertension as compared to group 3 followed by group 
2. (Table 5). 
The cardiovascular system (CVS) response to local an-
esthetic toxicity also is biphasic. Initially, the CVS is 
subject to stimulation; heart rate and blood pressure may 
increase This may be further precipitated in the local 
anaesthetic with vasoconstrictor Epinephrine. The above 
results in group 1 and 3 may be due to the biphasic re-
sponse and addition of epinephrine further accentuating 
the effect [11]. 
Tukey’s test used for post hoc analysis showed that the 
mean MTTES scores were significantly higher in Group 
1 (p<0.001) as compared to Group 2 & 3. MTTES score 
is lowest in Group 2 followed by Group 3. It is signifi-
cantly higher in Group 1 (Table 6).  
CONCLUSION 
Group 1 (topical and infiltration lignocaine) and 3 com-
binations showed higher MTTES score for the adverse 
effect profile, whereas Group 2 appeared safer in terms 
of both the variables. Thus, use of topical and infiltra-
tion lignocaine raises concerns regarding safety of this 
combination. 
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